Brand PerformancePOWERED BY
Main logo&Moja gazetka logo
Go to Alcohols
Go to Baker's good
Go to Beverages
Go to Breakfast products
Go to Bulk products nad pasta
Go to Cosmetics and skincare
Go to Dairy products and eggs
Go to Desserts and pastries
Go to Extra analyses
Go to For children
Go to For pets
Go to Frozen products
Go to Health
Go to Home and garden
Go to Household chemicals
Go to Hygiene
Go to Meat, fish and products
Go to Oils, vinegars
Go to Preserves and honey
Go to Ready-made and instant dishes and soups
Go to Sauces, dips
Go to Savory snacks
Go to Spices and bouillons
Go to Spreadable fats
Go to Sweets
Go to Tea, coffee and cocoa
Go to Toys and construction set
Brand Performance logo

Xylometazolin Teva

Cold and runny nose medicines
to receive information about changes in the popularity of this brand.

Xylometazolin Teva ranks 17th of 35 brands in the Cold and runny nose medicines category with a 1.91% share over the last four weeks.

The category leader is Gripex with a 15.79% share.

Its monthly share for October 2026 was 2.22%, compared with 1.96% the month before.

Its highest monthly share in the period shown, 3.05%, came in June 2025.

Data comes from the shopping lists of Listonic and Moja Gazetka app users and is updated weekly.

BRAND CHARTS
Udział procentowy marek w kategorii Cold and runny nose medicines
MarkaUdział procentowy
Gripex15.79%
Rutinoscorbin10.67%
Nasivin7.87%
Strepsils7.09%
Fervex6.05%
Theraflu5.08%
Tantum Verde5.04%
Otrivin5.03%
Neosine4.60%
Solpadeine3.52%
Sudafed3.41%
Cholinex2.46%
Rutinacea2.24%
Herbapect2.07%
Acatar2.00%
Mucosolvan1.94%
Xylometazolin Teva1.91%
Flegamina1.87%
Sinecod1.68%
Xylogel1.49%
Vicks1.44%
Scorbolamid1.40%
Coldrex1.18%
Cerutin1.03%
Aspirin C0.86%
Septolete0.44%
Nasic0.44%
Sterimar0.42%
Renopuren0.31%
Neo-angin0.24%
Flegamax0.19%
Febrisan0.17%
Tabcin Trend0.05%
Alka-seltzer0.02%
Talcid0.00%

Brand Xylometazolin Teva percentage share in the category Cold and runny nose medicines in the last month

The chart shows data for the 4 weeks leading up to the selected date. The information is updated every Monday and includes data up to Sunday.
1.91%Xylometazolin Teva
ALL BRANDS
Historical market share of brands in the Cold and runny nose medicines category (monthly)
MonthAlka-seltzerAspirin CCerutinCholinexColdrexFebrisanFervexFlegaminaGripexHerbapectNeo-anginNeosineRutinaceaRutinoscorbinScorbolamidSeptoleteStrepsilsSudafedTalcidTherafluVicksRenopurenSolpadeineTabcin TrendTantum VerdeMucosolvanAcatarNasivinOtrivinSterimarXylometazolin TevaFlegamaxXylogelSinecodNasic
November 20240.01%0.52%0.52%1.55%0.52%0.29%3.36%1.35%8.63%1.60%0.37%3.89%1.46%19.86%0.98%0.20%3.86%2.00%0.00%3.38%0.98%0.33%1.55%0.04%3.25%1.38%1.50%4.20%28.92%0.28%1.01%0.08%0.85%1.06%0.24%
December 20240.00%1.13%0.58%2.12%0.70%0.48%5.37%2.53%14.27%2.52%0.34%5.52%1.73%7.76%1.30%0.30%6.54%3.95%0.00%6.35%1.41%0.49%2.57%0.05%4.28%2.01%2.09%7.32%10.03%0.32%1.67%0.42%1.17%2.21%0.47%
January 20250.01%1.15%0.82%2.22%1.09%0.40%6.04%2.60%14.52%2.50%0.39%7.50%2.07%9.47%1.46%0.30%6.44%3.75%0.00%6.17%1.35%0.62%2.77%0.03%5.43%1.99%1.87%7.27%4.19%0.46%1.56%0.21%0.95%1.95%0.45%
February 20250.00%1.29%0.80%2.46%0.82%0.49%5.09%2.62%15.13%2.49%0.31%7.39%2.02%8.98%1.35%0.29%6.44%3.90%0.02%6.05%1.43%0.72%2.43%0.05%5.17%2.46%2.27%7.08%3.93%0.39%1.55%0.31%1.50%2.25%0.54%
March 20250.00%0.92%0.82%2.03%0.74%0.52%5.02%2.59%14.12%2.37%0.36%7.31%2.35%8.84%1.10%0.48%6.73%3.96%0.00%6.06%1.39%0.46%2.59%0.06%5.20%2.09%2.57%8.21%4.42%0.36%1.77%0.24%1.65%2.17%0.50%
April 20250.00%0.74%0.74%2.44%0.66%0.37%5.07%1.78%12.57%2.13%0.37%4.91%2.02%9.40%1.30%0.50%7.28%4.97%0.00%5.42%0.74%0.40%3.77%0.08%5.69%2.10%3.13%8.82%5.07%0.69%2.36%0.19%1.65%1.97%0.64%
May 20250.00%0.71%0.71%3.03%0.71%0.40%4.94%1.57%12.97%1.54%0.59%4.63%1.82%9.23%0.90%0.59%7.29%4.23%0.00%5.16%1.30%0.31%4.17%0.00%5.34%2.35%2.62%10.47%4.88%0.49%2.16%0.06%2.35%2.22%0.28%
June 20250.00%0.83%0.49%3.12%0.76%0.42%3.67%1.63%12.51%2.11%0.28%3.85%1.80%8.35%1.00%0.73%7.52%5.09%0.00%4.26%1.07%0.42%4.68%0.00%6.10%1.87%2.98%10.50%6.06%0.35%3.05%0.10%1.87%1.91%0.62%
July 20250.00%1.01%0.48%2.94%0.44%0.44%4.35%1.98%12.34%1.27%0.44%4.30%1.45%8.56%1.10%0.44%7.99%4.52%0.00%4.08%0.97%0.09%7.20%0.09%6.67%1.19%2.50%10.36%5.05%0.61%2.72%0.09%1.84%2.02%0.48%
August 20250.00%0.75%1.00%2.40%0.93%0.32%5.77%1.51%14.59%0.97%0.47%3.62%1.68%10.29%1.04%0.61%7.89%4.44%0.04%4.70%1.08%0.47%6.27%0.07%5.23%1.11%2.29%8.14%5.48%0.54%2.62%0.11%1.61%1.33%0.65%
September 20250.00%0.84%0.66%2.64%1.04%0.29%6.23%1.54%16.06%1.52%0.31%6.25%2.34%9.46%1.37%0.47%6.88%4.06%0.00%6.58%1.33%0.47%3.05%0.04%5.28%1.02%2.31%8.87%4.04%0.41%1.56%0.08%1.45%1.21%0.35%
October 20250.00%1.00%0.76%2.49%0.94%0.39%6.16%1.43%16.53%2.18%0.41%5.61%2.43%10.25%1.25%0.45%6.90%3.57%0.00%7.14%1.31%0.61%2.80%0.06%4.63%1.22%2.37%6.55%4.37%0.73%2.18%0.33%1.29%1.33%0.33%
November 20250.00%0.98%0.74%2.26%0.63%0.28%5.09%1.48%13.18%1.70%0.35%4.83%2.20%20.12%1.35%0.30%6.74%3.35%0.00%5.92%1.48%0.44%2.72%0.00%4.61%1.61%2.11%6.37%3.87%0.61%1.61%0.07%1.24%1.28%0.48%
December 20250.00%0.75%0.52%1.78%0.63%0.35%4.99%1.52%12.77%1.66%0.27%4.69%1.65%25.85%0.93%0.24%5.26%2.93%0.00%5.95%1.19%0.53%2.72%0.04%4.25%1.88%2.14%6.02%3.56%0.41%1.49%0.14%1.10%1.53%0.27%
January 20260.00%1.12%0.73%2.35%1.00%0.30%6.37%1.93%15.78%2.07%0.36%6.06%2.01%10.53%1.22%0.49%5.52%3.34%0.00%7.04%1.42%0.44%2.89%0.07%4.93%1.71%2.61%7.48%4.22%0.47%1.64%0.32%1.63%1.69%0.27%
February 20260.00%1.06%0.98%2.27%0.82%0.46%6.06%1.60%14.94%2.42%0.32%6.06%1.80%9.98%0.91%0.41%6.11%4.37%0.00%6.45%1.58%0.67%2.66%0.06%4.57%2.42%2.21%7.99%4.29%0.52%1.75%0.15%1.65%2.14%0.37%
March 20260.00%0.90%0.73%2.27%0.85%0.44%5.98%1.61%13.75%2.30%0.27%5.84%1.42%9.72%0.95%0.56%6.74%4.18%0.00%6.01%1.27%0.71%3.22%0.02%4.52%2.34%2.78%8.30%5.03%0.46%1.93%0.15%2.08%2.05%0.61%
April 20260.00%0.85%0.61%2.77%1.04%0.45%5.14%1.84%11.96%2.24%0.29%4.96%1.81%8.93%1.23%0.51%6.45%4.72%0.00%5.49%0.99%0.61%4.29%0.00%4.77%2.45%2.56%9.97%5.25%0.75%2.16%0.27%1.39%2.80%0.48%
May 20260.00%0.95%0.72%2.96%0.46%0.04%5.01%2.01%12.75%1.67%0.23%4.82%1.40%9.48%0.72%0.34%6.56%3.98%0.00%4.36%1.10%0.53%5.50%0.00%5.39%1.97%2.09%10.62%5.39%0.57%2.50%0.11%2.28%2.96%0.53%
June 20260.00%1.08%0.68%2.87%0.75%0.12%3.50%1.60%11.54%2.19%0.24%3.06%1.72%8.51%0.61%0.94%7.69%4.68%0.00%3.69%1.03%0.40%6.46%0.09%6.35%1.39%3.55%11.82%5.17%0.99%2.80%0.02%1.95%2.04%0.49%
July 20260.05%1.02%0.69%2.48%0.76%0.20%3.75%1.22%10.98%1.73%0.25%3.88%1.94%10.01%0.87%0.54%6.69%4.22%0.00%4.11%2.00%0.28%6.21%0.00%7.69%1.50%2.33%11.42%5.32%0.72%2.20%0.12%1.94%2.38%0.53%
August 20260.00%0.88%0.93%2.23%0.64%0.22%4.61%0.99%10.66%2.47%0.12%3.75%1.73%11.08%0.90%0.57%7.22%3.54%0.03%3.98%1.16%0.40%8.07%0.00%6.83%1.33%2.45%10.04%5.24%0.80%2.52%0.14%2.33%1.43%0.69%
September 20260.00%0.67%0.66%2.17%1.06%0.48%6.15%1.15%15.12%2.26%0.27%5.09%2.10%11.48%1.20%0.39%6.74%4.32%0.01%5.30%1.47%0.39%3.96%0.05%5.05%1.09%2.13%8.60%4.49%0.57%1.96%0.14%1.45%1.50%0.51%
October 20260.02%0.90%0.81%2.31%1.11%0.30%5.91%1.77%15.52%2.12%0.25%4.54%2.03%10.83%1.39%0.32%7.01%3.55%0.00%5.49%1.48%0.36%3.71%0.05%5.09%1.86%2.24%7.56%4.90%0.39%2.22%0.24%1.48%1.75%0.46%

Percentage share of tagged brands in individual months

How the share of the selected brands in the Cold and runny nose medicines category has changed over the months
The method of counting additions changed in June 2026 – comparisons with periods before that date may not be fully reliable.
Show data up to:
Range:
SUBCATEGORY CHARTS

Time to store

Shows how much time passes from adding a product from a given subcategory to a shopping list to the moment of purchase
197.9 h(8 days)
Cold and runny nose medicines
Type Planned | Over 72 h
Products added well in advance and purchased during planned, less frequent shopping trips. The long time from list to purchase reflects a deliberate, cyclical decision.
Comparison with the other subcategories in “Health”
Fertility drugs
Condoms
Heartburn medicines
Dietary supplements and vitamins for children
Dietary supplements and vitamins for adults
Protein supplements
Cold and runny nose medicines
Digestive medicines
0 h
47.9 h (2 days)
54.3 h (2 days)
62.3 h (3 days)
63.4 h (3 days)
178.1 h (7 days)
197.9 h (8 days)
408.2 h (17 days)
Median of the Health category: 408.2 h (17 days)
Allergy medicines
Contact lenses
Antispasmodics
Painkillers and anti-inflammatory drugs
Medicines for herpes and skin problems
Potency and libido medicines
449.5 h (19 days)
541.1 h (23 days)
544.7 h (23 days)
637.7 h (27 days)
824.1 h (34 days)
3,324.3 h (139 days)
Real Purchase Rate – Annual data for the Cold and runny nose medicines subcategory compared with the other subcategories in Health.
SubcategoryRPR (%)
Medicines for herpes and skin problems82%
Contact lenses82%
Condoms81%
Cold and runny nose medicines81%
Digestive medicines81%
Allergy medicines80%
Heartburn medicines80%
Protein supplements80%
Painkillers and anti-inflammatory drugs80%
Dietary supplements and vitamins for adults77%
Antispasmodics76%
Fertility drugs76%
Potency and libido medicines75%
Dietary supplements and vitamins for children70%

Real Purchase Rate (RPR)

Shows what percentage of products added to shopping lists were actually purchased. Annual data for the Cold and runny nose medicines subcategory compared with the other subcategories in Health.
Brand Loyalty Index (BLI) marki w kategorii Cold and runny nose medicines (miesięcznie)
MiesiącBLI (%)
2024-11-01T00:00:00100.00%
2024-12-01T00:00:00100.00%
2025-01-01T00:00:00100.00%
2025-02-01T00:00:000.00%
2025-03-01T00:00:00100.00%
2025-04-01T00:00:0063.71%
2025-05-01T00:00:0059.87%
2025-06-01T00:00:0052.07%
2025-07-01T00:00:0042.88%
2025-08-01T00:00:0027.51%
2025-09-01T00:00:0034.24%
2025-10-01T00:00:0035.19%
2025-11-01T00:00:0032.22%
2025-12-01T00:00:0042.24%
2026-01-01T00:00:0031.11%
2026-02-01T00:00:0030.53%
2026-03-01T00:00:0033.49%
2026-04-01T00:00:0035.38%
2026-05-01T00:00:0027.70%
2026-06-01T00:00:0023.53%
2026-07-01T00:00:0040.79%
2026-08-01T00:00:0045.62%
2026-09-01T00:00:0054.61%
2026-10-01T00:00:0041.96%
-58.00%

BLI - Brand Loyalty Index

The Brand Loyalty Index (BLI) indicates the degree of Listonic app users attachment to individual brands. It shows what percentage of products in category Cold and runny nose medicines added to the Listonic shopping list are entered with the brand.
Show data up to:
Range:
Bezwzględna liczba dodań produktów z kategorii Cold and runny nose medicines (miesięcznie)
MiesiącDodania z markąWszystkie dodania z kategorii
2024-11-01T00:00:0095109510
2024-12-01T00:00:0077047704
2025-01-01T00:00:0067236723
2025-02-01T00:00:0061340
2025-03-01T00:00:0050205020
2025-04-01T00:00:0037645908
2025-05-01T00:00:0032395410
2025-06-01T00:00:0028865543
2025-07-01T00:00:0022785312
2025-08-01T00:00:00279010141
2025-09-01T00:00:00488214259
2025-10-01T00:00:00489913921
2025-11-01T00:00:00459714266
2025-12-01T00:00:00776018372
2026-01-01T00:00:00590718988
2026-02-01T00:00:00538317630
2026-03-01T00:00:00409512228
2026-04-01T00:00:00375310607
2026-05-01T00:00:0026369516
2026-06-01T00:00:00425518080
2026-07-01T00:00:00608614921
2026-08-01T00:00:00578612683
2026-09-01T00:00:001069119578
2026-10-01T00:00:001032424602

Additions of a product from category Cold and runny nose medicines

Absolute data on adding products from category Cold and runny nose medicines with a brand compared to all additions from the category.
The method of counting additions changed in June 2026 – comparisons with periods before that date may not be fully reliable.
Show data up to:
Range:
Number of additions Cold and runny nose medicines
Number of additions Cold and runny nose medicines with the brand
The data for the analysis comes from shopping lists in Listonic and Moja Gazetka. The study has been supplemented with data from Moja Gazetka since October 2024.From June 2026 the method of counting additions has been refined: re-marking a product as to buy after it was previously checked off as bought (an "uncheck") now also counts as an addition to the list. This change affects data from June 2026 onwards – worth bearing in mind when comparing with earlier periods.
Is your brand missing from the comparison?
Want to increase your sales?Contact us
Privacy policy
© 2006-2026 Listonic. Listonic dev, Listonic ads and Brand Performance are part of Listonic.
Facebook iconLinkedIn icon